BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34589434)

  • 21. Tissue differences in the exosomal/small extracellular vesicle proteome and their potential as indicators of altered tissue metabolism.
    Garcia-Martin R; Brandao BB; Thomou T; Altindis E; Kahn CR
    Cell Rep; 2022 Jan; 38(3):110277. PubMed ID: 35045290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 23. Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population.
    Bleiberg H; Autier P; Huet F; Schrauwen AM; Staquet E; Delaunoit T; Hendlisz A; Wyns C; Panzer JM; Caucheteur B; Eisendrath P; Grivegnée A
    Ann Oncol; 2006 Aug; 17(8):1328-32. PubMed ID: 16728486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy.
    Ross FA; Park JH; Mansouri D; Little C; Di Rollo DG; Combet E; Van Wyk H; Horgan PG; McMillan DC; Roxburgh CSD
    Colorectal Dis; 2022 Feb; 24(2):188-196. PubMed ID: 34614299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver injury changes the biological characters of serum small extracellular vesicles and reprograms hepatic macrophages in mice.
    Lv XF; Zhang AQ; Liu WQ; Zhao M; Li J; He L; Cheng L; Sun YF; Qin G; Lu P; Ji YH; Ji JL
    World J Gastroenterol; 2021 Nov; 27(43):7509-7529. PubMed ID: 34887646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
    Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
    Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comparison of Blood Plasma Small Extracellular Vesicle Enrichment Strategies for Proteomic Analysis.
    Turner NP; Abeysinghe P; Kwan Cheung KA; Vaswani K; Logan J; Sadowski P; Mitchell MD
    Proteomes; 2022 Jun; 10(2):. PubMed ID: 35736799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
    Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
    PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.
    Yao L; Lao W; Zhang Y; Tang X; Hu X; He C; Hu X; Xu LX
    J Proteome Res; 2012 Jun; 11(6):3281-94. PubMed ID: 22506683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma.
    Wang H; Zhang B; Li X; Zhou D; Li Y; Jia S; Qi S; Xu A; Zhao X; Wang J; Bai Z; Cao B; Li N; Dai M; Chen H; Huang J
    Front Oncol; 2020; 10():1081. PubMed ID: 32793472
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study.
    Moravkova P; Kohoutova D; Vavrova J; Bures J
    Scand J Clin Lab Invest; 2020 May; 80(3):173-178. PubMed ID: 31856598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
    Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
    Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A facile "one-material" strategy for tandem enrichment of small extracellular vesicles phosphoproteome.
    Jiao F; Gao F; Liu Y; Fan Z; Xiang X; Xia C; Lv Y; Xie Y; Bai H; Zhang W; Qin W; Qian X
    Talanta; 2021 Feb; 223(Pt 2):121776. PubMed ID: 33298282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.